Media RelationsWestern University

Fetal exposure to nicotine alone increases long-term risk of obesity and metabolic syndrome

January 16, 2014

Many women are encouraged to quit smoking when they become pregnant using nicotine replacement therapy (NRT) whether as gum, transdermal patches, nasal spray or lozenges.    But new research from Western University has shown that nicotine alone from either smoking or NRT causes a wide range of long-term adverse reactions for the offspring, including an increased risk of obesity and metabolic syndrome by influencing the liver to produce more triglyceride.  The research, led by Daniel Hardy, PhD, of the Schulich School of Medicine & Dentistry is published online in the journal "Toxicology and Applied Pharmacology."

“We knew smoking was bad during pregnancy.  But the problem is one fifth of pregnant women in Canada continue to smoke, and 30 prospective studies have shown us that that babies born to smoking mothers have a 47 per cent increase in the odds of becoming overweight.  And here’s the interesting thing, that’s even after adjusting for mom’s diet and  socioeconomic status,” says Hardy, an assistant professor in the Departments of Obstetrics and Gynaecology, and Physiology and Pharmacology, and a scientist with the Children’s Health Research Institute.  “Our studies were designed to find if there is a biological basis between nicotine exposure from either NRT or smoking, and obesity and metabolic syndrome later in the offspring’s life.”

Working in collaboration with Alison Holloway, PhD, of McMaster University, Hardy gave pregnant laboratory rats the same amount of nicotine, adjusted for weight, that an average smoker receives (1 mg per  kg a day), which notably, is a lesser amount than is found in NRT (10 mg or the equivalent of 10 cigarettes).  The offspring were born smaller in size, but six months later when they reached adulthood, the rats had developed an increase in liver and circulating triglycerides, a hallmark of obesity.  The study also demonstrated that the nicotine-exposed liver, long-term, is making more triglycerides via transcriptional and epigenetic changes.

Hardy is also interested in finding out if increased perinatal doses of folic acid would prevent or reverse the nicotine damage to the developing liver.  Folic acid has been shown to reduce circulating triglycerides in animal studies, and smoking moms have been found to have low levels of folate so he says, it is conceivable.  He is also studying the long-term effects of nicotine on nursing babies.  

Hardy agrees that, compared to smoking, NRT is the lesser of two evils, but he says we need to rethink the dose and timing, and look more closely at the long-term safety and efficacy of nicotine in pregnancy on postnatal health and well-being.

This research was funded by the Canadian Institutes of Health Research.  Noelle Ma, a postgraduate student working in the Hardy laboratory, is the first author on the paper.

Media Contact: Kathy Wallis, Media Relations Officer, Schulich School of Medicine & Dentistry, Western University, 519-661-2111 ext. 81136, Kathy.wallis@schulich.uwo.ca
 
--

Follow Western Media Relations online:

Website: http://communications.uwo.ca/media/
RSS: http://feeds.feedburner.com/MediaWesternU
Twitter: https://twitter.com/mediawesternu